O45.011 Premature separation of placenta with afibrinogenemia, first trimester

Name of the Condition

• Premature Separation of Placenta with Afibrinogenemia, First Trimester (O45.011)

Summary

Premature separation of placenta with afibrinogenemia, first trimester is a pregnancy complication where the placenta detaches from the uterine wall before delivery, accompanied by a severe deficiency of fibrinogen (afibrinogenemia). This condition disrupts oxygen and nutrient transfer to the fetus and increases the risk of maternal hemorrhage due to impaired blood clotting. Prompt medical intervention is critical to manage maternal and fetal risks.

Causes

The exact cause of placental separation in the first trimester is often unclear, but it may result from trauma, uterine abnormalities, or vascular issues. Afibrinogenemia can arise from the placental separation itself, which triggers abnormal clotting processes, or from pre-existing coagulation disorders. Other potential triggers include hypertension or preeclampsia.

Risk Factors

• Hypertensive disorders of pregnancy (e.g., preeclampsia).
• Trauma to the abdomen.
• Uterine abnormalities or prior uterine surgery.
• Advanced maternal age.
• Smoking or substance use during pregnancy.
• History of placental abruption.
• Pre-existing coagulation disorders.

Symptoms

• Sudden, severe abdominal pain.
• Vaginal bleeding (may be absent in concealed cases).
• Uterine tenderness or rigidity.
• Fetal distress (e.g., decreased movement, abnormal heart rate).
• Signs of shock (e.g., dizziness, rapid pulse).

Diagnosis

Diagnosis is based on clinical presentation, ultrasound imaging to assess placental separation, and laboratory tests to evaluate coagulation status (e.g., fibrinogen levels, platelet count). Afibrinogenemia is confirmed by significantly low fibrinogen levels, and placental abruption is identified via ultrasound or clinical findings.

Treatment Options

Treatment focuses on stabilizing the mother and fetus. This may include intravenous fluids, blood transfusions, and fibrinogen replacement therapy. In severe cases, delivery may be necessary, even in the first trimester, to prevent maternal or fetal harm. Close monitoring of coagulation parameters is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of placental separation and afibrinogenemia, as well as the gestational age. Early intervention improves outcomes, but complications like hemorrhage or fetal loss may occur. Follow-up includes monitoring for recurrent abruption and managing coagulation disorders.

Complications

• Severe maternal hemorrhage.
• Fetal distress or loss.
• Disseminated intravascular coagulation (DIC).
• Uterine rupture.
• Long-term maternal coagulation issues.

Lifestyle & Prevention

• Manage hypertension or preeclampsia with prenatal care.
• Avoid abdominal trauma.
• Quit smoking or substance use during pregnancy.
• Attend regular prenatal visits to monitor placental health.

When to Seek Professional Help

Seek immediate medical attention for sudden abdominal pain, vaginal bleeding, or signs of shock during pregnancy. Prompt evaluation is critical to address placental separation and coagulation defects.

Tips for Medical Coders

Document the presence of afibrinogenemia and the first-trimester timing to support code O45.011. Include clinical details (e.g., fibrinogen levels, ultrasound findings) to confirm the diagnosis. Ensure documentation aligns with the specific trimester and coagulation defect for accurate coding.